🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Sin...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2019-03-06
Trial ID
NCT03903081
Treatments Being Tested
This randomized, double-blind, placebo-controlled, single ascending dose st...
Status
Completed
Location
Changi General Hospital; Clinical Trial & Research unit
Start Date
2013-12
Trial ID
NCT02015715
The purpose of this study is to evaluate the potential of high doses of rif...
Status
Completed
Location
University of Florida
Start Date
2013-09
Trial ID
NCT01408914
Treatments Being Tested
The study evaluates safety and efficacy of vaniprevir (MK7009), when admini...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-20
Trial ID
NCT00880763
Treatments Being Tested
A randomized, double-blind, placebo-controlled study to assess the effect o...
Status
Unknown
Location
Shourya clinic
Start Date
2024-07-25
Trial ID
NCT06496893
Treatments Being Tested
Oxidative stress has been investigated as a key factor in the pathogenesis ...
Status
Unknown
Location
Royan Institute
Start Date
2021-04-13
Trial ID
NCT05460858
Treatments Being Tested
This is a Phase 1, two-part, randomized, double blind, placebo controlled, ...
Status
Completed
Location
Scientia Clinical Research Ltd
Start Date
2022-06-07
Trial ID
NCT05364840
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Completed
Location
Frontage
Start Date
2011-03
Trial ID
NCT01328821
This was an open-label extension study in adolescent and adult (between 12 ...
Status
Terminated
Location
University of South Alabama Medical Center
Start Date
2007-03-15
Trial ID
NCT00448539
Treatments Being Tested
Cocaine abuse is associated with serious physical, psychiatric and social p...
Status
Terminated
Location
CHU Brugmann
Start Date
2019-03-01
Trial ID
NCT03423667
Treatments Being Tested